John Cavanagh to Imidazoles
This is a "connection" page, showing publications John Cavanagh has written about Imidazoles.
Connection Strength
2.072
-
Evaluation of a 2-aminoimidazole variant as adjuvant treatment for dermal bacterial infections. Drug Des Devel Ther. 2017; 11:153-162.
Score: 0.516
-
Membrane-permeabilizing activity of reverse-amide 2-aminoimidazole antibiofilm agents against Acinetobacter baumannii. Curr Drug Deliv. 2015; 12(2):223-30.
Score: 0.448
-
Identification of BfmR, a response regulator involved in biofilm development, as a target for a 2-Aminoimidazole-based antibiofilm agent. Biochemistry. 2012 Dec 11; 51(49):9776-8.
Score: 0.388
-
Evaluation of the toxicity of 2-aminoimidazole antibiofilm agents using both cellular and model organism systems. Drug Chem Toxicol. 2012 Jul; 35(3):310-5.
Score: 0.366
-
Structure of the Francisella response regulator QseB receiver domain, and characterization of QseB inhibition by antibiofilm 2-aminoimidazole-based compounds. Mol Microbiol. 2017 Oct; 106(2):223-235.
Score: 0.134
-
Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob Agents Chemother. 2010 May; 54(5):2112-8.
Score: 0.080
-
Control of bacterial biofilms with marine alkaloid derivatives. Mol Biosyst. 2008 Jun; 4(6):614-21.
Score: 0.070
-
Inhibition and dispersion of proteobacterial biofilms. Chem Commun (Camb). 2008 Apr 14; (14):1698-700.
Score: 0.069